In contrast to subcutaneous tumours, orthotopic tumoursresponded to both anti-CTLA-4 and anti-PD-1 monotherapies, resulting in asignificant increase in the survival of tumour-bearing mice (Fig. 5E). Here, CTLA4 is linked to neoplasm.